Euronext publishes Q3 2025 results and announces a share repurchase programme Euronext has delivered the sixth consecutive quarter of double-digit growth, driven by the expansion of non-volume-related businesses, resilient trading and clearing revenues and continued cost discipline. Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 6 November 2025 – Euronext, the leading European capital market infrastructure, today publishes its results for the third quarter of 2025. Q3 2025 revenue and income ...

Disclosure of total number of voting rights andnumber of shares forming the capitalas of October 31, 2025 Clichy, France – November 06, 2025 Article L 233-8-II of the French “Code de Commerce” and Article 223-16 of the General Regulations of the French “Autorité des Marchés Financiers”. As of October 31, 2025, the total number of issued shares of SOCIÉTÉ BIC is 41,621,162 shares, representing:- 58,357,733 voting rights,- 57,750,137 voting rights excluding shares without voting rights Contacts Brice ParisVP ...

Champfromier — Thursday, November 6, 2025 NINE-MONTH REVENUE DOWN -3.6% AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded, over the first 9 months of 2025, a published consolidated revenue of €730.7M. Consolidated revenue (from January 1 to September 30, 2025) in €m — unaudited20252024VariationPCC variation (1)1st quarter255.6263.5-3.0%-4.0 ...

Press Release Paris, 6 November 2025 2025 First Nine Months Results REVENUE UP 4.0% IN 9M25LIVE EXPERIENCES DRIVING GROWTH AT BANIJAY ENTERTAINMENT & LIVESTRONG PERFORMANCE AT BANIJAY GAMING, EVEN WITH HIGH 2024 COMPARISON & ADVERSE SPORTS RESULTS IN SEPTEMBER ADJUSTED EBITDA UP 9.8% IN 9M25 REINFORCING LEADERSHIP IN SPORTS BETTING AND ONLINE GAMING WITH TIPICO GROUP ACQUISITION 9M 2025 FINANCIAL HIGHLIGHTS1 Revenue up +4.0% to €3,224m in 9M 2025Adjusted EBITDA up +9.8% to €597m, Adjusted EBITDA margin up ...

Q3 2025 trading update Digital continues to drive organic revenue growth Paris, November 6th, 2025 Robust underlying revenue growth €926.1m in revenue in Q3 2025 -2.3% reported revenue growth-0.9% organic revenue growth, slightly above our expectationsc.+3% underlying organic revenue growth, i.e. excluding c.410bp comparison impact due to the 2024 Paris Olympic & Paralympic Games and UEFA Euro+7.6% organic digital revenue growth Guidance for Q4 2025: organic revenue growth expected around flat, includin ...

Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 Compelling kidney function data from VIVIAD Phase 2b study presented in late-breaking poster at ASN kidney week, the world’s premier nephrology meetingVIVIAD analyses continue to support varoglutamstat’s potential in kidney disease, and consistently provide further evidence for a beneficial impact on kidney function based on its proposed mechanism of action Halle (Saale) / ...

Aspo Plc ANNOUNCEMENT 6.11.2025 Aspo Plc: Share repurchase 6.11.2025 In the Helsinki Stock Exchange Trade date 6.11.2025 Bourse trade Buy Share ASPO Amount 1 300SharesAverage price/ share 6,8077EURTotal cost 8 850,01EUR Aspo Plc now holds a to ...

Press Release – No. 15 / 2025 Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results Copenhagen, Denmark, November 6, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that it will host a conference call on November 13, 2025, at 2:00 pm CET (8:00 am ET) following the announcement of financial results for the third q ...

TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) today announced its third quarter (Q3) and year-to-date (9M) results for the period ended September 30, 2025, and reported on its plan to double production by 2030, lower costs, and extend mine life across all operations. Management believes these initiatives provide an achievable path toward our goal of 250,000 to 300,000 GEOs Consolidated Annual Production by 2030. McEwen is advancing the following projects: The Fox Complex (Stock and ...

Trading statement for Q1 2025/26 (1 July - 30 September 2025) Growth in revenue and operating profit Revenue was up by 8% in Q1 2025/26 (11% at constant exchange rates) to DKK 124.6 million from DKK 115.6 million in the year-earlier period. The Q1 performance reflected continued growth in sales of instruments, consumables and services. Moreover, ChemoMetec is experiencing growing interest in its technology, not least the XcytoMatic platform, and this trend is expected to continue, affecting sales and earnin ...